Hedgehog signaling and truncated GLI1 in cancer

D Doheny, SG Manore, GL Wong, HW Lo - Cells, 2020 - mdpi.com
The hedgehog (HH) signaling pathway regulates normal cell growth and differentiation. As a
consequence of improper control, aberrant HH signaling results in tumorigenesis and …

STAT3 target genes relevant to human cancers

RL Carpenter, HW Lo - Cancers, 2014 - mdpi.com
Since its discovery, the STAT3 transcription factor has been extensively studied for its
function as a transcriptional regulator and its role as a mediator of development, normal …

[HTML][HTML] STAT1 in cancer: friend or foe?

Y Zhang, Z Liu - Discovery medicine, 2017 - discoverymedicine.com
The first STAT family member, STAT1, is an essential component of interferon (IFN)-
signaling, which mediates several cellular functions in response to stimulation by cytokines …

Targeting STAT3 in cancer and autoimmune diseases

T Gharibi, Z Babaloo, A Hosseini… - European journal of …, 2020 - Elsevier
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that is
activated downstream of a broad range of receptors particularly interleukin-6 (IL-6) family …

Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo

X Ding, AC Sharko, MSJ McDermott… - Proceedings of the …, 2022 - National Acad Sciences
Breast cancers (BrCas) that overexpress oncogenic tyrosine kinase receptor HER2 are
treated with HER2-targeting antibodies (such as trastuzumab) or small-molecule kinase …

Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast …

SR Sirkisoon, RL Carpenter, T Rimkus, A Anderson… - Oncogene, 2018 - nature.com
Signal transducer and activator of transcription 3 (STAT3), glioma oncogene homolog 1
(GLI1), and truncated GLI1 (tGLI1) are oncogenic transcription factors playing important …

[HTML][HTML] Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer

L Zhao, W Zhang, F Luan, X Chen, H Wu, Q He… - Biomedicine & …, 2023 - Elsevier
PD-L1 (programmed cell death ligand 1) is frequently up-regulated in tumors and is critical
in tumor immune escape. In addition to antibodies that block the interaction between PD-L1 …

Crosstalk between HER2 and PD-1/PD-L1 in breast cancer: from clinical applications to mathematical models

R Padmanabhan, HS Kheraldine, N Meskin, S Vranic… - Cancers, 2020 - mdpi.com
Breast cancer is one of the major causes of mortality in women worldwide. The most
aggressive breast cancer subtypes are human epidermal growth factor receptor-positive …

The HER2 signaling network in breast cancer—like a spider in its web

A Dittrich, H Gautrey, D Browell… - Journal of mammary gland …, 2014 - Springer
The human epidermal growth factor receptor 2 (HER2) is a major player in the survival and
proliferation of tumour cells and is overexpressed in up to 30% of breast cancer cases. A …

[HTML][HTML] EGFR and HER2 signaling in breast cancer brain metastasis

SR Sirkisoon, RL Carpenter, T Rimkus… - … in bioscience (Elite …, 2016 - ncbi.nlm.nih.gov
Breast cancer occurs in approximately 1 in 8 women and 1 in 37 women with breast cancer
succumbed to the disease. Over the past decades, new diagnostic tools and treatments …